COCP
Price:
$1.76
Market Cap:
$17.91M
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocr...[Read more]
Industry
Biotechnology
IPO Date
2012-02-22
Stock Exchange
NASDAQ
Ticker
COCP
According to Cocrystal Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.47M. This represents a change of -140.32% compared to the average of -3641002.50 of the last 4 quarters.
The mean historical Enterprise Value of Cocrystal Pharma, Inc. over the last ten years is 277.04M. The current 1.47M Enterprise Value has changed -47.02% with respect to the historical average. Over the past ten years (40 quarters), COCP's Enterprise Value was at its highest in in the March 2015 quarter at 1.00B. The Enterprise Value was at its lowest in in the December 2022 quarter at -20968150.00.
Average
277.04M
Median
164.78M
Minimum
-20968150.00
Maximum
868.73M
Discovering the peaks and valleys of Cocrystal Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.06%
Maximum Annual Enterprise Value = 868.73M
Minimum Annual Increase = -103.32%
Minimum Annual Enterprise Value = -20968150.00
Year | Enterprise Value | Change |
---|---|---|
2023 | -7975280.00 | -61.96% |
2022 | -20968150.00 | -103.32% |
2021 | 631.10M | -27.35% |
2020 | 868.73M | 370.72% |
2019 | 184.55M | 87.48% |
2018 | 98.44M | -32.12% |
2017 | 145.01M | -46.65% |
2016 | 271.79M | -50.79% |
2015 | 552.27M | 1.06% |
2014 | 47.48M | -34.36% |
The current Enterprise Value of Cocrystal Pharma, Inc. (COCP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
200.72M
5-year avg
331.09M
10-year avg
277.04M
Cocrystal Pharma, Inc.’s Enterprise Value is less than ZIVO Bioscience, Inc. (72.87M), less than RenovoRx, Inc. (15.60M), less than Tempest Therapeutics, Inc. (18.09M), less than Ikena Oncology, Inc. (48.14M), less than Catalyst Biosciences, Inc. (19.42M), greater than Moleculin Biotech, Inc. (-1761449.00), greater than Pulmatrix, Inc. (-3294806.00), greater than Cyclacel Pharmaceuticals, Inc. (-4960306.00), less than Akari Therapeutics, Plc (25.17M), greater than Quoin Pharmaceuticals, Ltd. (-450170.00), less than Blue Water Vaccines, Inc. (8.67M), greater than PaxMedica, Inc. Common Stock (817.83K), greater than Revelation Biosciences, Inc. (-3459443.00), less than Hillstream BioPharma, Inc. (1.48M), less than Onconova Therapeutics, Inc. (4.51M), greater than Bio-Path Holdings, Inc. (-634090.00), greater than Allarity Therapeutics, Inc. (-16000922.00), less than Kiromic BioPharma, Inc. (13.29M), less than Virax Biolabs Group Limited (5.36M), greater than Biodexa Pharmaceuticals Plc (-2098715.31),
Company | Enterprise Value | Market cap |
---|---|---|
72.87M | $72.29M | |
15.60M | $27.34M | |
18.09M | $28.96M | |
48.14M | $84.93M | |
19.42M | $19.42M | |
-1761449.00 | $7.25M | |
-3294806.00 | $7.49M | |
-4960306.00 | $1.03M | |
25.17M | $28.35M | |
-450170.00 | $2.67M | |
8.67M | $3.41M | |
817.83K | $1.14M | |
-3459443.00 | $3.08M | |
1.48M | $4.17M | |
4.51M | $20.90M | |
-634090.00 | $3.32M | |
-16000922.00 | $1.91M | |
13.29M | $1.50M | |
5.36M | $8.73M | |
-2098715.31 | $3.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cocrystal Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cocrystal Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cocrystal Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cocrystal Pharma, Inc. (COCP)?
What is the 3-year average Enterprise Value for Cocrystal Pharma, Inc. (COCP)?
What is the 5-year average Enterprise Value for Cocrystal Pharma, Inc. (COCP)?
How does the current Enterprise Value for Cocrystal Pharma, Inc. (COCP) compare to its historical average?